Koshinski Asset Management
EW icon

Koshinski Asset Management’s Edwards Lifesciences EW Stock Holding History

Koshinski Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Sell
4,645
-28
-0.6% -$2.35K 0.02% 513
2026
Q1 		$374K Hold
4,673
– – 0.02% 512
2025
Q4 		$398K Hold
4,673
– – 0.03% 487
2025
Q3 		$363K Buy
4,673
+9
+0.2% +$703 0.02% 512
2025
Q2 		$365K Sell
4,664
-3
-0.1% -$224 0.03% 475
2025
Q1 		$338K Sell
4,667
-31
-0.7% -$2.22K 0.03% 459
2024
Q4 		$348M Sell
4,698
-1,302
-22% -$91.1K 0.03% 452
2024
Q3 		$396K Buy
+6,000
New +$436K 0.03% 428
2023
Q3 		– Sell
-6,404
Closed -$604K – 587
2023
Q2 		$604K Sell
6,404
-1,124
-15% -$97.7K 0.06% 303
2023
Q1 		$623K Buy
7,528
+165
+2% +$13K 0.06% 286
2022
Q4 		$549K Buy
+7,363
New +$567K 0.05% 348
2022
Q3 		– Sell
-7,018
Closed -$667K – 588
2022
Q2 		$667K Buy
7,018
+92
+1% +$9.52K 0.07% 304
2022
Q1 		$815K Buy
6,926
+37
+0.5% +$4.15K 0.07% 291
2021
Q4 		$892K Sell
6,889
-2,821
-29% -$329K 0.07% 281
2021
Q3 		$1.1M Buy
9,710
+3,766
+63% +$430K 0.1% 231
2021
Q2 		$616K Sell
5,944
-3,476
-37% -$328K 0.08% 285
2021
Q1 		$788K Buy
+9,420
New +$796K 0.08% 274
2020
Q3 		– Sell
-9,244
Closed -$639K – 521
2020
Q2 		$639K Buy
9,244
+1
+0% +$71 0.1% 235
2020
Q1 		$581K Buy
9,243
+60
+0.7% +$4.33K 0.12% 215
2019
Q4 		$711K Buy
9,183
+1,653
+22% +$129K 0.12% 240
2019
Q3 		$552K Hold
7,530
– – 0.38% 80
2019
Q2 		$464K Hold
7,530
– – 0.19% 152
2019
Q1 		$480 Hold
7,530
– – 0.13% 203
2018
Q4 		$384K Hold
7,530
– – 0.09% 262
2018
Q3 		$437K Buy
+7,530
New +$368K 0.06% 355
2016
Q4 		– Sell
-5,400
Closed -$217K – 290
2016
Q3 		$217K Buy
+5,400
New +$203K 0.11% 257

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Koshinski Asset Management's EW Position: Q2 2026 in Review

Koshinski Asset Management reduced its Edwards Lifesciences (EW) stake by 0.6% in Q2 2026, selling an estimated $2.35K and leaving 4,645 shares worth $420K. The position accounts for 0.02% of the portfolio, ranked #513.

Koshinski Asset Management first reported a position in EW in Q3 2016 and has held it in 26 quarters since. The position peaked at $348M in Q4 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Koshinski Asset Management held 4,645 shares of Edwards Lifesciences worth $420K as of Q2 2026.
  • Koshinski Asset Management sold 28 Edwards Lifesciences shares in Q2 2026, an estimated $2.35K.
  • Edwards Lifesciences made up 0.02% of Koshinski Asset Management's portfolio in Q2 2026, its #513 holding.
  • Koshinski Asset Management first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 26 quarters since.
  • Koshinski Asset Management's Edwards Lifesciences position peaked at $348M in Q4 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.